MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
Top Cited Papers
Open Access
- 7 November 2011
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 31 (28), 3357-3369
- https://doi.org/10.1038/onc.2011.500
Abstract
MicroRNAs (miRNAs) are believed to have fundamental roles in tumorigenesis and have great potential for the diagnosis and treatment of cancer. However, the roles of miRNAs in hepatocellular carcinogenesis are still not fully elucidated. We investigated the aberrantly expressed miRNAs involved in hepatoma by comparison of miRNA expression profiles in cancerous hepatocytes with normal primary human hepatocytes, and 37 dysregulated miRNAs were screened out by twofold change with a significant difference (P<0.05). Clustering analysis based on 13 miRNAs with changes over 15-folds showed that the miRNA expression patterns between the cancerous and normal hepatocytes were clearly different. Among the 13 miRNAs, we found that miR-375 was significantly downregulated in hepatocellular carcinoma (HCC) tissues and cell lines. Overexpression of miR-375 in liver cancer cells decreased cell proliferation, clonogenicity, migration/invasion and also induced G1 arrest and apoptosis. To unveil the molecular mechanism of miR-375-mediated phenotype in hepatoma cells described above, we examined the putative targets using bioinformatics tools and found that astrocyte elevated gene-1 (AEG-1) was a potential target of miR-375. Then we demonstrated that miR-375 bound directly to the 3'-untranslated region of AEG-1 and inhibited the expression of AEG-1. TaqMan quantitative reverse transcriptase-PCR and western blot analysis showed that miR-375 expression was inversely correlated with AEG-1 expression in HCC tissues. Knockdown of AEG-1 by RNAi in HCC cells, similar to miR-375 overexpression, suppressed tumor properties. Ectopic expression of AEG-1, conversely, could partially reverse the antitumor effects of miR-375. In a mouse model, therapeutic administration of cholesterol-conjugated 2'-O-methyl-modified miR-375 mimics (Chol-miR-375) could significantly suppress the growth of hepatoma xenografts in nude mice. In conclusion, our findings indicate that miR-375 targets AEG-1 in HCC and suppresses liver cancer cell growth in vitro and in vivo, and highlight the therapeutic potential of miR-375 in HCC treatment.Keywords
This publication has 40 references indexed in Scilit:
- Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancerMedical Oncology, 2010
- The Multifaceted Role of MTDH/AEG-1 in Cancer ProgressionClinical Cancer Research, 2009
- MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2009
- MicroRNA involvement in hepatocellular carcinomaJournal of Cellular and Molecular Medicine, 2008
- The impact of microRNAs on protein outputNature, 2008
- MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumorsJournal of Hepatology, 2008
- Identification of metastasis-related microRNAs in hepatocellular carcinomaJournal of Hepatology, 2008
- Microarray analysis of microRNA expression in hepatocellular carcinoma and non‐tumorous tissues without viral hepatitisJournal of Gastroenterology and Hepatology, 2007
- Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular CarcinomaCancer Research, 2007
- Astrocyte elevated gene-1: Recent insights into a novel gene involved in tumor progression, metastasis and neurodegenerationPharmacology & Therapeutics, 2007